Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04675476 · ClinicalTrials.gov registry record · NA

A Patient and Provider Intervention to Address Health Disparities in Lung Cancer Screening

A NA study of Lung Cancer, sponsored by Georgetown University.

Recruiting
Registry status
NA
Development phase
368
Enrollment target
1
Study location

NCT04675476 is a NA study of Lung Cancer that is actively recruiting participants, run by Georgetown University. The registered enrollment target is 368 participants, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (61% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04675476, a NA study of Lung Cancer, is actively recruiting participants, sponsored by Georgetown University.

RECRUITING
Registry status
NA
Development phase
368 participants
Enrollment target
1
Study location

Study Summary

To test the impact of a multilevel intervention on primary (provider-patient communication, intentions, and knowledge) and secondary (screening referrals and completion) outcomes.

Conditions Studied

Interventions

  • BEHAVIORAL Provider Prompt & Patient Outreach and Education

Study Locations (1)

District of Columbia

  • MedStar Health - Washington D.C.

Trial Details

FieldValue
Enrollment Target 368 participants
Start Date 2024-03-11
Est. Completion 2026-02-28
Phase NA

Sponsor

Georgetown University

227 total trials

What the Registry Record Tells You About NCT04675476

The ClinicalTrials.gov registry entry for NCT04675476 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 368 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (61% lower). The listed sponsor is Georgetown University, which has 227 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Lung Cancer appearing as the primary indexed condition, and to 1 intervention - of which Provider Prompt & Patient Outreach and Education is the first listed.

NCT04675476 reports 1 study location spanning 1 distinct geographic area - top geographies include District of Columbia.

Frequently Asked Questions

What is clinical trial NCT04675476 about?

NCT04675476 is a clinical study titled "A Patient and Provider Intervention to Address Health Disparities in Lung Cancer Screening". To test the impact of a multilevel intervention on primary (provider-patient communication, intentions, and knowledge) and secondary (screening referrals and completion) outcomes.

What is the current status of trial NCT04675476?

This trial is currently recruiting. It is a NA study. The enrollment target is 368 participants. The study started on 2024-03-11. Estimated completion is 2026-02-28.

What conditions does trial NCT04675476 study?

This clinical trial studies the following conditions: Lung Cancer.

What interventions are being tested in trial NCT04675476?

The interventions under investigation include: Provider Prompt & Patient Outreach and Education (BEHAVIORAL).

Who is sponsoring clinical trial NCT04675476?

This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04675476 being conducted?

This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Lung Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.